This site is intended for healthcare professionals

Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Antitetanus immunoglobulin

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Tetanus immunoglobulin (TIG) gives passive immunity to tetanus infection.

  • helps to remove unbound tetanus toxins (1)
  • is indicated to provide immediate protection in
    • individuals with tetanus prone wounds who are not fully vaccinated (or up to date for their age) against tetanus.
    • vaccinated individuals who have a ‘high-risk’ tetanus prone wound e.g. a wound which is also heavily contaminated with manure/soil or an abscess in an injection site (2)

Since most of the tetanus prone wounds in vaccinated individuals do not require immunoglobulin, TIG should be restricted to patients in whom it is truly indicated so that supplies can be conserved for those at greatest risk (2).

Reference:

Related pages

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.